Leukoencephalopathies in adulthood

Seminars in Neurology

Volumn 32, Issue 1, 2012, Pages 85-94

  Tillema, Jan Mendelt ^a   Renaud, Deborah L ^a  

^a MAYO CLINIC   (United States)

Author keywords

adult onset; autosomal dominant; leukodystrophy; leukoencephalopathy

Indexed keywords

ADRENOLEUKODYSTROPHY; ADULT; ADULT ONSET AUTOSOMAL DOMINANT LEUKODYSTROPHY; ADULT POLYGLUCOSAN BODY DISEASE; ADULTHOOD; ALEXANDER DISEASE; ARTICLE; AUTOSOMAL DOMINANT DISORDER; BRAIN ATROPHY; CADASIL; CEREBROTENDINOUS XANTHOMATOSIS; CHILDHOOD ADRENOLEUKODYSTROPHY; CORPUS CALLOSUM; DEMYELINATING DISEASE; DIFFUSE LEUKOENCEPHALOPATHIES WITH NEUROAXONAL SPHEROID; FRAGILE X ASSOCIATED TREMOR ATAXIA SYNDROME; GLOBOID CELL LEUKODYSTROPHY; HUMAN; LEUKOENCEPHALOPATHY; METACHROMATIC LEUKODYSTROPHY; NEUROIMAGING; NEUROLOGIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; X CHROMOSOME LINKED DISORDER;

ADULT; AGE OF ONSET; CENTRAL NERVOUS SYSTEM; HEREDITARY CENTRAL NERVOUS SYSTEM DEMYELINATING DISEASES; HUMANS; LEUKOENCEPHALOPATHIES;

EID: 84858147192     PISSN: 02718235     EISSN: 10989021     Source Type: Journal    
DOI: 10.1055/s-0032-1306391     Document Type: Article

References (125)

1. Gieselmann V, Zlotogora J, Harris A, Wenger DA, Morris CP. Molecular genetics of metachromatic leukodystrophy. Hum Mutat: 1994; 4 4 233 242 (Pubitemid 24361693)
2. Bosch EP, Hart MN. Late adult-onset metachromatic leukodystrophy. Dementia and polyneuropathy in a 63-year-old man. Arch Neurol: 1978; 35 7 475 477 (Pubitemid 8355419)
3. Rauschka H, Colsch B, Baumann N., et al. Late-onset metachromatic leukodystrophy: genotype strongly influences phenotype. Neurology: 2006; 67 5 859 863 (Pubitemid 44394203)
4. Baumann N, Turpin JC, Lefevre M, Colsch B. Motor and psycho-cognitive clinical types in adult metachromatic leukodystrophy: genotype/phenotype relationships? J Physiol Paris: 2002; 96 3-4 301 306 (Pubitemid 36090368)
5. Hageman AT, Gabrels FJ, de Jong JG., et al. Clinical symptoms of adult metachromatic leukodystrophy and arylsulfatase A pseudodeficiency. Arch Neurol: 1995; 52 4 408 413
6. Mahmood A, Berry J, Wenger DA., et al. Metachromatic leukodystrophy: a case of triplets with the late infantile variant and a systematic review of the literature. J Child Neurol: 2010; 25 5 572 580
7. Hyde TM, Ziegler JC, Weinberger DR. Psychiatric disturbances in metachromatic leukodystrophy. Insights into the neurobiology of psychosis. Arch Neurol: 1992; 49 4 401 406
8. Fressinaud C, Vallat JM, Masson M, Jauberteau MO, Baumann N, Hugon J. Adult-onset metachromatic leukodystrophy presenting as isolated peripheral neuropathy. Neurology: 1992; 42 7 1396 1398
9. Coulter-Mackie MB, Applegarth DA, Toone JR, Gagnier L, Anzarut AR, Hendson G. Isolated peripheral neuropathy in atypical metachromatic leukodystrophy: a recurrent mutation. Can J Neurol Sci: 2002; 29 2 159 163 (Pubitemid 34733404)
10. Sadeh M, Kuritzky A, Ben-David E, Goldhammer Y. Adult metachromatic leukodystrophy with an unusual relapsing-remitting course. Postgrad Med J: 1992; 68 797 192 195
11. Hohenschutz C, Eich P, Friedl W, Waheed A, Conzelmann E, Propping P. Pseudodeficiency of arylsulfatase A: a common genetic polymorphism with possible disease implications. Hum Genet: 1989; 82 1 45 48 (Pubitemid 19116228)
12. van der Knaap MS, Valk J, Barkhof F. Magnetic resonance of myelination and myelin disorders. 3rd ed. Berlin, New York Springer: 2005
13. Eichler F, Grodd W, Grant E., et al. Metachromatic leukodystrophy: a scoring system for brain MR imaging observations. AJNR Am J Neuroradiol: 2009; 30 10 1893 1897
14. de Hosson LD, van de Warrenburg BP, Preijers FW., et al. Adult metachromatic leukodystrophy treated by allo-SCT and a review of the literature. Bone Marrow Transplant: 2011; 46 8 1071 1076
15. Solders G, Celsing G, Hagenfeldt L, Ljungman P, Isberg B, Ringdn O. Improved peripheral nerve conduction, EEG and verbal IQ after bone marrow transplantation for adult metachromatic leukodystrophy. Bone Marrow Transplant: 1998; 22 11 1119 1122 (Pubitemid 28554224)
16. Ko ON, Day J, Nieder M, Gerson SL, Lazarus HM, Krivit W. Allogeneic mesenchymal stem cell infusion for treatment of metachromatic leukodystrophy (MLD) and Hurler syndrome (MPS-IH). Bone Marrow Transplant: 2002; 30 4 215 222 (Pubitemid 35023593)
17. Meuleman N, Vanhaelen G, Tondreau T., et al. Reduced intensity conditioning haematopoietic stem cell transplantation with mesenchymal stromal cells infusion for the treatment of metachromatic leukodystrophy: a case report. Haematologica: 2008; 93 1 e11 e13
18. Wenger DA, Rafi MA, Luzi P. Molecular genetics of Krabbe disease (globoid cell leukodystrophy): diagnostic and clinical implications. Hum Mutat: 1997; 10 4 268 279 (Pubitemid 27430501)
19. Lissens W, Arena A, Seneca S., et al. A single mutation in the GALC gene is responsible for the majority of late onset Krabbe disease patients in the Catania (Sicily, Italy) region. Hum Mutat: 2007; 28 7 742
20. Tappino B, Biancheri R, Mort M., et al. Identification and characterization of 15 novel GALC gene mutations causing Krabbe disease. Hum Mutat: 2010; 31 12 E1894 E1914
21. Fiumara A, Barone R, Arena A., et al. Krabbe leukodystrophy in a selected population with high rate of late onset forms: longer survival linked to c.121G > A (p.Gly41Ser) mutation. Clin Genet: 2010
22. Barone R, Brühl K, Stoeter P, Fiumara A, Pavone L, Beck M. Clinical and neuroradiological findings in classic infantile and late-onset globoid-cell leukodystrophy (Krabbe disease). Am J Med Genet: 1996; 63 1 209 217
23. Wang C, Melberg A, Weis J, Mnsson JE, Raininko R. The earliest MR imaging and proton MR spectroscopy abnormalities in adult-onset Krabbe disease. Acta Neurol Scand: 2007; 116 4 268 272 (Pubitemid 47373479)
24. Farina L, Bizzi A, Finocchiaro G., et al. MR imaging and proton MR spectroscopy in adult Krabbe disease. AJNR Am J Neuroradiol: 2000; 21 8 1478 1482
25. Bajaj NP, Waldman A, Orrell R, Wood NW, Bhatia KP. Familial adult onset of Krabbe's disease resembling hereditary spastic paraplegia with normal neuroimaging. J Neurol Neurosurg Psychiatry: 2002; 72 5 635 638 (Pubitemid 34462819)
26. Mosser J, Lutz Y, Stoeckel ME., et al. The gene responsible for adrenoleukodystrophy encodes a peroxisomal membrane protein. Hum Mol Genet: 1994; 3 2 265 271 (Pubitemid 24060941)
27. Ferrer I, Aubourg P, Pujol A. General aspects and neuropathology of X-linked adrenoleukodystrophy. Brain Pathol: 2010; 20 4 817 830
28. Singh I, Pujol A. Pathomechanisms underlying X-adrenoleukodystrophy: a three-hit hypothesis. Brain Pathol: 2010; 20 4 838 844
29. Moser HW. Adrenoleukodystrophy: phenotype, genetics, pathogenesis and therapy. Brain: 1997; 120 Pt 8 1485 1508 (Pubitemid 27344713)
30. Matsumoto H, Hanajima R, Terao Y., et al. Efferent and afferent evoked potentials in patients with adrenomyeloneuropathy. Clin Neurol Neurosurg: 2010; 112 2 131 136
31. Chaudhry V, Moser HW, Cornblath DR. Nerve conduction studies in adrenomyeloneuropathy. J Neurol Neurosurg Psychiatry: 1996; 61 2 181 185 (Pubitemid 26264329)
32. Eichler F, Mahmood A, Loes D., et al. Magnetic resonance imaging detection of lesion progression in adult patients with X-linked adrenoleukodystrophy. Arch Neurol: 2007; 64 5 659 664 (Pubitemid 46789832)
33. Teriitehau C, Adamsbaum C, Merzoug V, Kalifa G, Tourbah A, Aubourg P. [Subtle brain abnormalities in adrenomyeloneuropathy]. J Radiol: 2007; 88 7-8 Pt 1 957 961
34. van Geel BM, Bezman L, Loes DJ, Moser HW, Raymond GV. Evolution of phenotypes in adult male patients with X-linked adrenoleukodystrophy. Ann Neurol: 2001; 49 2 186 194 (Pubitemid 32157994)
35. Dubey P, Fatemi A, Huang H., et al. Diffusion tensor-based imaging reveals occult abnormalities in adrenomyeloneuropathy. Ann Neurol: 2005; 58 5 758 766 (Pubitemid 41552551)
36. Fatemi A, Smith SA, Dubey P., et al. Magnetization transfer MRI demonstrates spinal cord abnormalities in adrenomyeloneuropathy. Neurology: 2005; 64 10 1739 1745 (Pubitemid 40695808)
37. Dubey P, Fatemi A, Barker PB., et al. Spectroscopic evidence of cerebral axonopathy in patients with "pureo" adrenomyeloneuropathy. Neurology: 2005; 64 2 304 310
38. Moser AB, Kreiter N, Bezman L., et al. Plasma very long chain fatty acids in 3,000 peroxisome disease patients and 29,000 controls. Ann Neurol: 1999; 45 1 100 110 (Pubitemid 29036438)
39. Berger J, Pujol A, Aubourg P, Forss-Petter S. Current and future pharmacological treatment strategies in X-linked adrenoleukodystrophy. Brain Pathol: 2010; 20 4 845 856
40. Sourander P, Wlinder J. Hereditary multi-infarct dementia. Morphological and clinical studies of a new disease. Acta Neuropathol: 1977; 39 3 247 254 (Pubitemid 8166981)
41. Sourander P, Wälinder J. Hereditary multi-infarct dementia. Lancet: 1977; 1 8019 1015
42. Davous P. CADASIL: a review with proposed diagnostic criteria. Eur J Neurol: 1998; 5 3 219 233 (Pubitemid 28256610)
43. Tournier-Lasserve E, Joutel A, Melki J., et al. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy maps to chromosome 19q12. Nat Genet: 1993; 3 3 256 259 (Pubitemid 23096563)
44. Bousser MG, Tournier-Lasserve E. Summary of the proceedings of the First International Workshop on CADASIL, Paris, May 19-21, 1993. Stroke: 1994; 25 3 704 707 (Pubitemid 24067090)
45. Joutel A, Corpechot C, Ducros A., et al. Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia. Nature: 1996; 383 6602 707 710 (Pubitemid 26360644)
46. Chabriat H, Joutel A, Dichgans M, Tournier-Lasserve E, Bousser MG. Cadasil. Lancet Neurol: 2009; 8 7 643 653
47. Desmond DW, Moroney JT, Lynch T, Chan S, Chin SS, Mohr JP. The natural history of CADASIL: a pooled analysis of previously published cases. Stroke: 1999; 30 6 1230 1233 (Pubitemid 29259179)
48. Dichgans M, Mayer M, Uttner I., et al. The phenotypic spectrum of CADASIL: clinical findings in 102 cases. Ann Neurol: 1998; 44 5 731 739 (Pubitemid 28516043)
49. Chabriat H, Vahedi K, Iba-Zizen MT., et al. Clinical spectrum of CADASIL: a study of 7 families. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Lancet: 1995; 346 8980 934 939
50. Reyes S, Viswanathan A, Godin O., et al. Apathy: a major symptom in CADASIL. Neurology: 2009; 72 10 905 910
51. Velizarova R, Mourand I, Serafini A, Crespel A, Gelisse P. Focal epilepsy as first symptom in CADASIL. Seizure: 2011; 20 6 502 504
52. Chabriat H, Levy C, Taillia H., et al. Patterns of MRI lesions in CADASIL. Neurology: 1998; 51 2 452 457 (Pubitemid 28406321)
53. Ruchoux MM, Chabriat H, Bousser MG, Baudrimont M, Tournier-Lasserve E. Presence of ultrastructural arterial lesions in muscle and skin vessels of patients with CADASIL. Stroke: 1994; 25 11 2291 2292 (Pubitemid 24338393)
54. Low WC, Junna M, Börjesson-Hanson A., et al. Hereditary multi-infarct dementia of the Swedish type is a novel disorder different from NOTCH3 causing CADASIL. Brain: 2007; 130 Pt 2 357 367 (Pubitemid 46181090)
55. Yamamoto Y, Craggs L, Baumann M, Kalimo H, Kalaria RN. Review: molecular genetics and pathology of hereditary small vessel diseases of the brain. Neuropathol Appl Neurobiol: 2011; 37 1 94 113
56. Brenner M, Johnson AB, Boespflug-Tanguy O, Rodriguez D, Goldman JE, Messing A. Mutations in GFAP, encoding glial fibrillary acidic protein, are associated with Alexander disease. Nat Genet: 2001; 27 1 117 120 (Pubitemid 32044531)
57. Stumpf E, Masson H, Duquette A., et al. Adult Alexander disease with autosomal dominant transmission: a distinct entity caused by mutation in the glial fibrillary acid protein gene. Arch Neurol: 2003; 60 9 1307 1312 (Pubitemid 37099641)
58. Seil FJ, Schochet SS Jr, Earle KM. Alexander's disease in an adult. Report of a case. Arch Neurol: 1968; 19 5 494 502
59. Quinlan RA, Brenner M, Goldman JE, Messing A. GFAP and its role in Alexander disease. Exp Cell Res: 2007; 313 10 2077 2087 (Pubitemid 46842983)
60. Li R, Johnson AB, Salomons G., et al. Glial fibrillary acidic protein mutations in infantile, juvenile, and adult forms of Alexander disease. Ann Neurol: 2005; 57 3 310 326 (Pubitemid 40343953)
61. Messing A, Brenner M. Alexander disease: GFAP mutations unify young and old. Lancet Neurol: 2003; 2 2 75 (Pubitemid 37443325)
62. Pareyson D, Fancellu R, Mariotti C., et al. Adult-onset Alexander disease: a series of eleven unrelated cases with review of the literature. Brain: 2008; 131 Pt 9 2321 2331
63. Prust M, Wang J, Morizono H., et al. GFAP mutations, age at onset, and clinical subtypes in Alexander disease. Neurology: 2011; 77 13 1287 1294
64. van der Knaap MS, Naidu S, Breiter SN., et al. Alexander disease: diagnosis with MR imaging. AJNR Am J Neuroradiol: 2001; 22 3 541 552 (Pubitemid 32221425)
65. van der Knaap MS, Ramesh V, Schiffmann R., et al. Alexander disease: ventricular garlands and abnormalities of the medulla and spinal cord. Neurology: 2006; 66 4 494 498 (Pubitemid 43739875)
66. Farina L, Pareyson D, Minati L., et al. Can MR imaging diagnose adult-onset Alexander disease? AJNR Am J Neuroradiol: 2008; 29 6 1190 1196 (Pubitemid 351954892)
67. Eldridge R, Anayiotos CP, Schlesinger S., et al. Hereditary adult-onset leukodystrophy simulating chronic progressive multiple sclerosis. N Engl J Med: 1984; 311 15 948 953 (Pubitemid 14002057)
68. Coffeen CM, McKenna CE, Koeppen AH., et al. Genetic localization of an autosomal dominant leukodystrophy mimicking chronic progressive multiple sclerosis to chromosome 5q31. Hum Mol Genet: 2000; 9 5 787 793 (Pubitemid 30162763)
69. Marklund L, Melin M, Melberg A, Giedraitis V, Dahl N. Adult-onset autosomal dominant leukodystrophy with autonomic symptoms restricted to 1.5 Mbp on chromosome 5q23. Am J Med Genet B Neuropsychiatr Genet: 2006; 141B 6 608 614 (Pubitemid 44434661)
70. Dos Santos MM, Grond-Ginsbach C, Aksay SS., et al. Adult-onset autosomal dominant leukodystrophy due to LMNB1 gene duplication. J Neurol: 2011
71. Melberg A, Hallberg L, Kalimo H, Raininko R. MR characteristics and neuropathology in adult-onset autosomal dominant leukodystrophy with autonomic symptoms. AJNR Am J Neuroradiol: 2006; 27 4 904 911 (Pubitemid 44897747)
72. Schwankhaus JD, Katz DA, Eldridge R, Schlesinger S, McFarland H. Clinical and pathological features of an autosomal dominant, adult-onset leukodystrophy simulating chronic progressive multiple sclerosis. Arch Neurol: 1994; 51 8 757 766 (Pubitemid 24242599)
73. Padiath QS, Saigoh K, Schiffmann R., et al. Lamin B1 duplications cause autosomal dominant leukodystrophy. Nat Genet: 2006; 38 10 1114 1123 (Pubitemid 44470356)
74. Schuster J, Sundblom J, Thuresson AC., et al. Genomic duplications mediate overexpression of lamin B1 in adult-onset autosomal dominant leukodystrophy (ADLD) with autonomic symptoms. Neurogenetics: 2011; 12 1 65 72
75. Sundblom J, Melberg A, Kalimo H, Smits A, Raininko R. MR imaging characteristics and neuropathology of the spinal cord in adult-onset autosomal dominant leukodystrophy with autonomic symptoms. AJNR Am J Neuroradiol: 2009; 30 2 328 335
76. Meijer IA, Simoes-Lopes AA, Laurent S., et al. A novel duplication confirms the involvement of 5q23.2 in autosomal dominant leukodystrophy. Arch Neurol: 2008; 65 11 1496 1501
77. Lossos A, Meiner Z, Barash V., et al. Adult polyglucosan body disease in Ashkenazi Jewish patients carrying the Tyr329Ser mutation in the glycogen-branching enzyme gene. Ann Neurol: 1998; 44 6 867 872 (Pubitemid 28558247)
78. Klein CJ, Boes CJ, Chapin JE., et al. Adult polyglucosan body disease: case description of an expanding genetic and clinical syndrome. Muscle Nerve: 2004; 29 2 323 328 (Pubitemid 38166858)
79. Ziemssen F, Sindern E, Schröder JM., et al. Novel missense mutations in the glycogen-branching enzyme gene in adult polyglucosan body disease. Ann Neurol: 2000; 47 4 536 540 (Pubitemid 30194615)
80. Sindern E, Ziemssen F, Ziemssen T., et al. Adult polyglucosan body disease: a postmortem correlation study. Neurology: 2003; 61 2 263 265 (Pubitemid 36875318)
81. Berkhoff M, Weis J, Schroth G, Sturzenegger M. Extensive white-matter changes in case of adult polyglucosan body disease. Neuroradiology: 2001; 43 3 234 236 (Pubitemid 32194481)
82. Klein CM, Bosch EP, Dyck PJ. Probable adult polyglucosan body disease. Mayo Clin Proc: 2000; 75 12 1327 1331
83. Massa R, Bruno C, Martorana A, de Stefano N, van Diggelen OP, Federico A. Adult polyglucosan body disease: proton magnetic resonance spectroscopy of the brain and novel mutation in the GBE1 gene. Muscle Nerve: 2008; 37 4 530 536 (Pubitemid 351501983)
84. Klein CJ. Adult polyglucosan body disease. In: Pagon RA, Bird TD, Dolan CR, Stephens K., eds. GeneReviews. Seattle University of Washington: 1993
85. Milde P, Guccion JG, Kelly J, Locatelli E, Jones RV. Adult polyglucosan body disease. Arch Pathol Lab Med: 2001; 125 4 519 522
86. Cali JJ, Hsieh CL, Francke U, Russell DW. Mutations in the bile acid biosynthetic enzyme sterol 27-hydroxylase underlie cerebrotendinous xanthomatosis. J Biol Chem: 1991; 266 12 7779 7783 (Pubitemid 21906434)
87. Oftebro H, Björkhem I, Skrede S, Schreiner A, Pederson JI. Cerebrotendinous xanthomatosis: a defect in mitochondrial 26-hydroxylation required for normal biosynthesis of cholic acid. J Clin Invest: 1980; 65 6 1418 1430 (Pubitemid 10122384)
88. Moghadasian MH, Salen G, Frohlich JJ, Scudamore CH. Cerebrotendinous xanthomatosis: a rare disease with diverse manifestations. Arch Neurol: 2002; 59 4 527 529 (Pubitemid 34289955)
89. Menkes JH, Schimschock JR, Swanson PD. Cerebrotendinous xanthomatosis. The storage of cholestanol within the nervous system. Arch Neurol: 1968; 19 1 47 53
90. Verrips A, Hoefsloot LH, Steenbergen GC., et al. Clinical and molecular genetic characteristics of patients with cerebrotendinous xanthomatosis. Brain: 2000; 123 Pt 5 908 919 (Pubitemid 30224187)
91. Federico A, Dotti MT. Cerebrotendinous xanthomatosis: clinical manifestations, diagnostic criteria, pathogenesis, and therapy. J Child Neurol: 2003; 18 9 633 638 (Pubitemid 37258469)
92. Verrips A, Nijeholt GJ, Barkhof F., et al. Spinal xanthomatosis: a variant of cerebrotendinous xanthomatosis. Brain: 1999; 122 Pt 8 1589 1595 (Pubitemid 29374133)
93. Siebner HR, Berndt S, Conrad B. Cerebrotendinous xanthomatosis without tendon xanthomas mimicking Marinesco-Sjoegren syndrome: a case report. J Neurol Neurosurg Psychiatry: 1996; 60 5 582 585 (Pubitemid 26147904)
94. Verrips A, van Engelen BG, Wevers RA., et al. Presence of diarrhea and absence of tendon xanthomas in patients with cerebrotendinous xanthomatosis. Arch Neurol: 2000; 57 4 520 524 (Pubitemid 30212126)
95. Federico A, Dotti MT, Lor F, Nuti R. Cerebrotendinous xanthomatosis: pathophysiological study on bone metabolism. J Neurol Sci: 1993; 115 1 67 70 (Pubitemid 23090187)
96. Barkhof F, Verrips A, Wesseling P., et al. Cerebrotendinous xanthomatosis: the spectrum of imaging findings and the correlation with neuropathologic findings. Radiology: 2000; 217 3 869 876
97. De Stefano N, Dotti MT, Mortilla M, Federico A. Magnetic resonance imaging and spectroscopic changes in brains of patients with cerebrotendinous xanthomatosis. Brain: 2001; 124 Pt 1 121 131 (Pubitemid 32055994)
98. Dotti MT, Federico A, Signorini E., et al. Cerebrotendinous xanthomatosis (van Bogaert-Scherer-Epstein disease): CT and MR findings. AJNR Am J Neuroradiol: 1994; 15 9 1721 1726 (Pubitemid 24311425)
99. Vanrietvelde F, Lemmerling M, Mespreuve M, Crevits L, De Reuck J, Kunnen M. MRI of the brain in cerebrotendinous xanthomatosis (van Bogaert-Scherer- Epstein disease). Eur Radiol: 2000; 10 4 576 578 (Pubitemid 30202638)
100. Berginer VM, Salen G, Shefer S. Long-term treatment of cerebrotendinous xanthomatosis with chenodeoxycholic acid. N Engl J Med: 1984; 311 26 1649 1652 (Pubitemid 15183994)
101. Federico A, Dotti MT. Treatment of cerebrotendinous xanthomatosis. Neurology: 1994; 44 11 2218
102. Verrips A, Wevers RA, Van Engelen BG., et al. Effect of simvastatin in addition to chenodeoxycholic acid in patients with cerebrotendinous xanthomatosis. Metabolism: 1999; 48 2 233 238 (Pubitemid 29072281)
103. Axelsson R, Röyttä M, Sourander P, Akesson HO, Andersen O. Hereditary diffuse leucoencephalopathy with spheroids. Acta Psychiatr Scand Suppl: 1984; 314 1 65
104. Baba Y, Ghetti B, Baker MC., et al. Hereditary diffuse leukoencephalopathy with spheroids: clinical, pathologic and genetic studies of a new kindred. Acta Neuropathol: 2006; 111 4 300 311
105. Hancock N, Poon M, Taylor B, McLean C. Hereditary diffuse leucoencephalopathy with spheroids. J Neurol Neurosurg Psychiatry: 2003; 74 9 1345 1347
106. Keegan BM, Giannini C, Parisi JE, Lucchinetti CF, Boeve BF, Josephs KA. Sporadic adult-onset leukoencephalopathy with neuroaxonal spheroids mimicking cerebral MS. Neurology: 2008; 70 13 Pt 2 1128 1133 (Pubitemid 351464770)
107. Martinez-Saez E, Shah S, Costa C., et al. Adult onset leukodystrophy with neuroaxonal spheroids and demyelinating plaque-like lesions. Neuropathology: 2011
108. Mendes A, Pinto M, Vieira S, Castro L, Carpenter S. Adult-onset leukodystrophy with axonal spheroids. J Neurol Sci: 2010; 297 1-2 40 45
109. Van Gerpen JA, Wider C, Broderick DF, Dickson DW, Brown LA, Wszolek ZK. Insights into the dynamics of hereditary diffuse leukoencephalopathy with axonal spheroids. Neurology: 2008; 71 12 925 929
110. van der Knaap MS, Naidu S, Kleinschmidt-Demasters BK, Kamphorst W, Weinstein HC. Autosomal dominant diffuse leukoencephalopathy with neuroaxonal spheroids. Neurology: 2000; 54 2 463 468 (Pubitemid 30078085)
111. Marotti JD, Tobias S, Fratkin JD, Powers JM, Rhodes CH. Adult onset leukodystrophy with neuroaxonal spheroids and pigmented glia: report of a family, historical perspective, and review of the literature. Acta Neuropathol: 2004; 107 6 481 488 (Pubitemid 38765388)
112. Freeman SH, Hyman BT, Sims KB., et al. Adult onset leukodystrophy with neuroaxonal spheroids: clinical, neuroimaging and neuropathologic observations. Brain Pathol: 2009; 19 1 39 47
113. Terada S, Ishizu H, Yokota O., et al. An autopsy case of hereditary diffuse leukoencephalopathy with spheroids, clinically suspected of Alzheimer's disease. Acta Neuropathol: 2004; 108 6 538 545 (Pubitemid 39534596)
114. Berry-Kravis E, Potanos K, Weinberg D, Zhou L, Goetz CG. Fragile X-associated tremor/ataxia syndrome in sisters related to X-inactivation. Ann Neurol: 2005; 57 1 144 147 (Pubitemid 40053328)
115. Hagerman RJ, Leavitt BR, Farzin F., et al. Fragile-X-associated tremor/ataxia syndrome (FXTAS) in females with the FMR1 premutation. Am J Hum Genet: 2004; 74 5 1051 1056 (Pubitemid 38568975)
116. Greco CM, Berman RF, Martin RM., et al. Neuropathology of fragile X-associated tremor/ataxia syndrome (FXTAS). Brain: 2006; 129 Pt 1 243 255 (Pubitemid 43063775)
117. Jacquemont S, Hagerman RJ, Leehey M., et al. Fragile X premutation tremor/ataxia syndrome: molecular, clinical, and neuroimaging correlates. Am J Hum Genet: 2003; 72 4 869 878 (Pubitemid 36403306)
118. Loesch DZ, Huggins RM, Hagerman RJ. Phenotypic variation and FMRP levels in fragile X. Ment Retard Dev Disabil Res Rev: 2004; 10 1 31 41 (Pubitemid 38375351)
119. Jacquemont S, Hagerman RJ, Leehey MA., et al. Penetrance of the fragile X-associated tremor/ataxia syndrome in a premutation carrier population. JAMA: 2004; 291 4 460 469 (Pubitemid 38129750)
120. Grigsby J, Brega AG, Jacquemont S., et al. Impairment in the cognitive functioning of men with fragile X-associated tremor/ataxia syndrome (FXTAS). J Neurol Sci: 2006; 248 1-2 227 233 (Pubitemid 44647291)
121. Hall DA, Berry-Kravis E, Jacquemont S., et al. Initial diagnoses given to persons with the fragile X associated tremor/ataxia syndrome (FXTAS). Neurology: 2005; 65 2 299 301 (Pubitemid 41022379)
122. Brunberg JA, Jacquemont S, Hagerman RJ., et al. Fragile X premutation carriers: characteristic MR imaging findings of adult male patients with progressive cerebellar and cognitive dysfunction. AJNR Am J Neuroradiol: 2002; 23 10 1757 1766 (Pubitemid 35304116)
123. Cohen S, Masyn K, Adams J., et al. Molecular and imaging correlates of the fragile X-associated tremor/ataxia syndrome. Neurology: 2006; 67 8 1426 1431 (Pubitemid 44632067)
124. Loesch DZ, Litewka L, Brotchie P, Huggins RM, Tassone F, Cook M. Magnetic resonance imaging study in older fragile X premutation male carriers. Ann Neurol: 2005; 58 2 326 330 (Pubitemid 41098892)
125. Jacquemont S, Hagerman RJ, Hagerman PJ, Leehey MA. Fragile-X syndrome and fragile X-associated tremor/ataxia syndrome: two faces of FMR1. Lancet Neurol: 2007; 6 1 45 55 (Pubitemid 44880272)